84 related articles for article (PubMed ID: 8172561)
1. Nonimmune activation of the classical complement pathway.
Gewurz H; Ying SC; Jiang H; Lint TF
Behring Inst Mitt; 1993 Dec; (93):138-47. PubMed ID: 8172561
[No Abstract] [Full Text] [Related]
2. Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions.
Ji SR; Wu Y; Potempa LA; Liang YH; Zhao J
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):935-41. PubMed ID: 16456095
[TBL] [Abstract][Full Text] [Related]
3. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q.
Ying SC; Gewurz AT; Jiang H; Gewurz H
J Immunol; 1993 Jan; 150(1):169-76. PubMed ID: 8417122
[TBL] [Abstract][Full Text] [Related]
4. Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein.
Gronemus JQ; Hair PS; Crawford KB; Nyalwidhe JO; Cunnion KM; Krishna NK
Mol Immunol; 2010; 48(1-3):305-13. PubMed ID: 20728940
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q.
Nauta AJ; Bottazzi B; Mantovani A; Salvatori G; Kishore U; Schwaeble WJ; Gingras AR; Tzima S; Vivanco F; Egido J; Tijsma O; Hack EC; Daha MR; Roos A
Eur J Immunol; 2003 Feb; 33(2):465-73. PubMed ID: 12645945
[TBL] [Abstract][Full Text] [Related]
6. Complement C1q-target proteins recognition is inhibited by electric moment effectors.
Roumenina L; Bureeva S; Kantardjiev A; Karlinsky D; Andia-Pravdivy JE; Sim R; Kaplun A; Popov M; Kishore U; Atanasov B
J Mol Recognit; 2007; 20(5):405-15. PubMed ID: 17929239
[TBL] [Abstract][Full Text] [Related]
7. Probing the C1q-binding site on human C-reactive protein by site-directed mutagenesis.
Agrawal A; Volanakis JE
J Immunol; 1994 Jun; 152(11):5404-10. PubMed ID: 8189060
[TBL] [Abstract][Full Text] [Related]
8. Origin of the classical complement pathway: Lamprey orthologue of mammalian C1q acts as a lectin.
Matsushita M; Matsushita A; Endo Y; Nakata M; Kojima N; Mizuochi T; Fujita T
Proc Natl Acad Sci U S A; 2004 Jul; 101(27):10127-31. PubMed ID: 15218103
[TBL] [Abstract][Full Text] [Related]
9. Prion protein activates and fixes complement directly via the classical pathway: implications for the mechanism of scrapie agent propagation in lymphoid tissue.
Mitchell DA; Kirby L; Paulin SM; Villiers CL; Sim RB
Mol Immunol; 2007 Apr; 44(11):2997-3004. PubMed ID: 17337056
[TBL] [Abstract][Full Text] [Related]
10. Human neutrophil peptide-1 inhibits both the classical and the lectin pathway of complement activation.
Groeneveld TW; Ramwadhdoebé TH; Trouw LA; van den Ham DL; van der Borden V; Drijfhout JW; Hiemstra PS; Daha MR; Roos A
Mol Immunol; 2007 Jul; 44(14):3608-14. PubMed ID: 17448537
[TBL] [Abstract][Full Text] [Related]
11. Functional domains of the human C1q A-chain.
Trinder PK; Maeurer MJ; Kaul M; Petry E; Loos M
Behring Inst Mitt; 1993 Dec; (93):180-8. PubMed ID: 8172566
[TBL] [Abstract][Full Text] [Related]
12. Studies on the interactions between C-reactive protein and complement proteins.
Bíró A; Rovó Z; Papp D; Cervenak L; Varga L; Füst G; Thielens NM; Arlaud GJ; Prohászka Z
Immunology; 2007 May; 121(1):40-50. PubMed ID: 17244159
[TBL] [Abstract][Full Text] [Related]
13. Structure and function of the long pentraxin PTX3 glycosidic moiety: fine-tuning of the interaction with C1q and complement activation.
Inforzato A; Peri G; Doni A; Garlanda C; Mantovani A; Bastone A; Carpentieri A; Amoresano A; Pucci P; Roos A; Daha MR; Vincenti S; Gallo G; Carminati P; De Santis R; Salvatori G
Biochemistry; 2006 Sep; 45(38):11540-51. PubMed ID: 16981714
[TBL] [Abstract][Full Text] [Related]
14. C1q and tumor necrosis factor superfamily: modularity and versatility.
Kishore U; Gaboriaud C; Waters P; Shrive AK; Greenhough TJ; Reid KB; Sim RB; Arlaud GJ
Trends Immunol; 2004 Oct; 25(10):551-61. PubMed ID: 15364058
[TBL] [Abstract][Full Text] [Related]
15. Activation of classical pathway of complement cascade by soluble oligomers of prion.
Dumestre-Pérard C; Osmundson J; Lemaire-Vieille C; Thielens N; Grives A; Favier B; Csopaki F; Jamin M; Gagnon J; Cesbron JY
Cell Microbiol; 2007 Dec; 9(12):2870-9. PubMed ID: 17991046
[TBL] [Abstract][Full Text] [Related]
16. Solid-phase classical complement activation by C-reactive protein (CRP) is inhibited by fluid-phase CRP-C1q interaction.
Sjöwall C; Wetterö J; Bengtsson T; Askendal A; Almroth G; Skogh T; Tengvall P
Biochem Biophys Res Commun; 2007 Jan; 352(1):251-8. PubMed ID: 17113035
[TBL] [Abstract][Full Text] [Related]
17. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
[TBL] [Abstract][Full Text] [Related]
18. Haemonchus contortus calreticulin binds to C-reactive protein of its host, a novel survival strategy of the parasite.
Suchitra S; Anbu KA; Rathore DK; Mahawar M; Singh BP; Joshi P
Parasite Immunol; 2008; 30(6-7):371-4. PubMed ID: 18422872
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of the interaction of C1q with immunoglobulins and the classical pathway of complement activation by steroids and triterpenoids sulfates.
Bureeva S; Andia-Pravdivy J; Symon A; Bichucher A; Moskaleva V; Popenko V; Shpak A; Shvets V; Kozlov L; Kaplun A
Bioorg Med Chem; 2007 May; 15(10):3489-98. PubMed ID: 17383882
[TBL] [Abstract][Full Text] [Related]
20. C1q in autoimmune diseases: rheumatoid arthritis.
Maeurer MJ; Trinder PK; Störkel S; Loos M
Behring Inst Mitt; 1993 Dec; (93):262-78. PubMed ID: 8172576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
